CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 19 enrolled
Drug / intervention
Jublia (Efinaconazole 10% Topical Solution)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03098615
NCT03098615Phase 4Completed
CompareCT.gov

An Investigator Initiated Pilot Study Evaluating the Efficacy of Efinaconazole 10% Solution (Jublia) for the Treatment of Onychomycosis With Dermatophytomas

University of Alabama at Birmingham·interventional·Posted Apr 4, 2017·Updated Dec 10, 2019

In Brief

A Phase 4 clinical trial evaluating Jublia (Efinaconazole 10% Topical Solution) for Onychomycosis and Dermatophytosis. Completed, enrolled 19 participants across 1 site.

Detailed Summary

This study will examine how Jublia affects dermatophytomas, which are difficult to treat with other therapeutic options.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOnychomycosis, Dermatophytosis
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 4, 2017
Enrollment StartSep 1, 2015
Primary CompletionMay 1, 2017
Study CompletionJul 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 9.2 years ago

Interventions

Jublia (Efinaconazole 10% Topical Solution)drug

Efinaconazole 10% Topical Solution will be applied to the great toenail with the DLSO and dermatophytoma.